I am also keen to hear from the ones that like the NBS story to let me know what their theory is behind the IPO and the reasoning of offloading Trustdefender.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025